Price premiums enjoyed by global drugmakers over local counterparts are at risk as governments in emerging markets clamp down on pharmaceutical costs. In addition to China's probe of 60 drugmakers, Turkey is enforcing cuts, Brazil is supporting local drugmakers, and India's relations with Western drugmakers have worsened.

Full Story:

Related Summaries